While you’re here… help us stay here.
Are you enjoying open access to policy and research published by a broad range of organisations? Please donate today so that we can continue to provide this service.
Report
Money calls the shots: pharma's response to the COVID-19 vaccines crisis
Publisher
COVID-19
Corporate social responsibility
Immunisation
Intellectual property
Disease management
Infectious diseases
Pharmaceuticals
Resources
| Attachment | Size |
|---|---|
 Money calls the shots: pharma's response to the COVID-19 vaccines crisis
|
3.1 MB |
Description
In September 2021, Amnesty International published A double dose of inequality, which assessed the extent to which the pharmaceutical industry was restricting access to COVID-19 vaccines.
This report updates that assessment of five leading vaccine manufacturers, AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna Inc., and Pfizer Inc. It also includes for the first time an assessment of the two largest Chinese vaccine producers, China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Sinovac Biotech Ltd. (Sinovac).
Publication Details
Copyright:
Amnesty International 2022
License type:
CC BY-NC-ND
Access Rights Type:
open
Post date:
15 Feb 2022
